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The E. coli lipid A precursor lipid X (NZ,@-diacylglucosamine l-phosphate) activates calmodulin-dependent cyclic nu- 
cleotide phosphodiesterase in a noncooperative, calcium-independent manner by increasing its V,,, and decreasing its 
K,,, for substrate. The glycolipid produces half-maximal activation at 11 pg/ml and does not further enhance activation 
by calcium-calmodulin. Lipid X activation of phosphodiesterase requires the presence of the @-linked hydroxymyristoyl 
residue. These findings suggest that lipid X could produce some of its biological effects by modulating intracellular CAMP 
levels. 
Lipopolysaccharide; Lipid A precursor; Cyclic-nucleotide phosphodiesterase; cyclic AMP 
1. INTRODUCTION 
Lipopolysaccharide (LPS), a major component 
of the outer membrane of Gram-negative micro- 
organisms, produces a variety of pathophysiolog- 
ical effects in mammals. The lipid A portion of 
LPS is responsible for most of its stimulatory 
effects on B-lymphocytes, neutrophils, and macro- 
phages [ 11. Relatively little is known of the 
biochemical basis for these effects. Chemically 
defined lipid A precursors are useful model com- 
pounds for studying the biochemical mechanisms 
and structural requirements of lipid A-induced 
responses. Lipid X, a monosaccharide isolated 
from Escherichia coli mutants [2], is a potent B- 
cell mitogen [3] and induces spreading, prostaglan- 
din E2 synthesis, and tumor necrosis factor pro- 
duction by macrophages [4,5]. 
Lipid X (lo-150 yg/ml) has been shown to ac- 
tivate purified protein kinase C by substituting for 
phosphatidylserine [6]. Since this enzyme, along 
with the cyclic AMP-dependent protein kinase 
system, is a major pathway for signal transduction 
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in immune cells [7], it has been suggested that pro- 
tein kinase C mediates some of the effects of lipid 
X. Here, we provide evidence that lipid X may also 
influence cyclic AMP-dependent processes by 
stimulating the hydrolysis of cyclic nucleotide 
second messengers by phosphodiesterase. 
2. MATERIALS AND METHODS 
E. coli lipid X, dephosphorylated lipid X (dephospho-X) and 
Nz-monoacylglucosamine l-phosphate were obtained from 
Lipidex. Histone type Ila and 4-methylumbelliferyl phosphate 
were purchased from Sigma. Methylanthraniloyl-cyclic GMP 
was obtained from Molecular Probes. All other chemicals were 
reagent grade. 
Cyclic nucleotide phosphodiesterase and calcineurin were 
purified from bovine brain as described by Sharma et al. [8]. 
Calmodulin was purified from bovine brain by the procedure of 
Gopalakrishna and Anderson [9]. Phosphodiesterase was 
assayed fluorometrically as described by Johnson et al. [IO]. 
The assay (1 ml volume) contained 10 mM Mops, pH 7.0, 8pM 
methylanthraniloyl-cyclic GMP, 5 mM MgClz, 90 mM KC1 and 
200 pM EGTA. Lipid X and its analogs were dispersed in this 
buffer by bath sonication. Calcineurin was assayed with the 
fluorescent substrate 4-methylumbelliferyl phosphate as 
described by Anthony et al. [12]. 
3. RESULTS AND DISCUSSION 
Dispersed lipid X (l-50 pg/ml) stimulated cyclic 
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Fig. 1. Activation of phosphodiesterase (3.4 g&ml) by lipid X 
(0), dephospho-X (A) and monoacylglucosamine l-phosphate 
(A). (Inset) Hill plot of phosphodiesterase activation by lipid X. 
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Fig.2. Comparison of lipid X- and calcium/calmodulin- 
stimulated phosphodiesterase activity and their additive effects. 
Phosphodiesterase (1.4 pg/ml) was monitored as a function of 
time under the following conditions: (0) unstimulated, (0) 
lipid X (40pg/ml) with EGTA (200aM), (A) lipid X (40pg/ml) 
with calcium (0.73 mM), (A) lipid X (40 pg/ml) with calcium 
and calmodulin (56 nM), (0) lipid X (15 pg/ml) with calcium 
and calmodulin (56 nM), and (0) calcium and calmodulin (56 
nM). 
nucleotide phosphodiesterase in a dose-dependent 
manner in the absence of calcium (fig.1). Activa- 
tion by lipid X was noncooperative with a Hill 
coefficient of 0.98 (fig. 1, inset). Lipid X produced 
half-maximal activation at 11 pug/ml and 
stimulated phosphodiesterase 16-fold over basal 
activity at 50 pug/ml. Dephospho-X (50 pg/ml) 
stimulated phosphodiesterase 11.3-fold. Deacyl- 
ated lipid X (N*-monoacylglucosamine l-phos- 
phate, 50 pg/ml) produced only 5.3-fold 
stimulation, suggesting that the 03-acyl group is an 
essential structural requirement for activation by 
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Fig.3. Effects of calcium/calmodulin, lipid X and dephospho-X 
on the K, and V,,,, of phosphodiesterase. Hydrolysis of 
methylanthraniloyl-cyclic GMP by phosphodiesterase (0.5 
@g/ml) was assayed at 25°C in the presence of lipid X (50 
@g/ml) (0). dephospho-X (50 pg/ml) (A), and calcium (0.73 
mM)/calmodulin (56 nM) (0). Unstimulated substrate 
hydrolysis (0) by phosphodiesterase (5.0pg/ml) was monitored 
in the absence of calcium. The method of Walker and Schmidt 
[l l] was used to estimate K, and V,,,. 
lipid X. Interestingly, stimulation of phospho- 
diesterase occurred at lipid X concentrations 
similar to those which activate B-lymphocytes and 
macrophages [3,4]. Further, the structural require- 
ments for phosphodiesterase stimulation parallel 
those for activation of immune cells. Selective 
03-deacylation of lipid X abolishes its ability to 
activate B-lymphocytes and macrophages. De- 
phospho-X is incapable of macrophage activation, 
but is partially mitogenic toward B-lymphocytes 
]3,41. 
The time course of cyclic nucleotide hydrolysis 
in the presence of lipid X (40 pug/ml) and EGTA 
(200 PM) was not affected by the addition of 
calcium (0.73 mM), indicating that activation by 
lipid X is calcium-independent (fig. 2). Simul- 
taneous stimulation by lipid X and saturating 
amounts of calcium-calmodulin was not additive. 
Although the degree of stimulation produced by 
lipid X and calcium-calmodulin was greater than 
that produced by lipid X alone, it was less than 
that obtained by maximal stimulation with 
calcium-calmodulin (56 nM). These findings sug- 
gest that calmodulin and lipid X activate 
phosphodiesterase by similar, noncomplementary 
mechanisms. 
Certain fatty acids, phospholipids and ganglio- 
sides can partially activate phosphodiesterase in a 
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calcium-independent manner by increasing its Vmax 
[13-151. In contrast, stimulation by lipid X 
produced catalytically favorable changes in both 
K, and I’,,,,, (fig.3). Lipid X (50pg/ml) decreased 
the K,,, from 5.6 to 2.7 PM, and increased the I’,,,,, 
by 27-fold. Dephospho-X decreased the K, to 3.5 
,uM, but increased Vmax by only 17-fold. In com- 
parison, stimulation by calcium-calmodulin (56 
nM) decreased the K,, to 3.6 PM and increased 
I’,,, by 37-fold. With regard to its effect on kinetic 
constants, lipid X stimulates phosphodiesterase in 
a manner more similar to calmodulin than other 
lipids. 
We examined the effect of lipid X on 
calcineurin, a calmodulin-dependent phosphatase 
which interacts with acidic phospholipids and 
undergoes significant changes in its activity [16]. 
Lipid X (50 pug/ml) had negligible effects on 
calcineurin, producing only 1.2-fold stimulation in 
the presence of 0.73 mM calcium (not shown). This 
finding suggests that activation of phosphodies- 
terase by lipid X is a somewhat selective interaction 
which does not occur with all calmodulin-depen- 
dent enzymes. 
The biochemical mechanisms involved in 
mediating the complex effects of LPS on inflam- 
matory cells have not been fully explained. Its 
structurally defined precursor, lipid X, has been 
shown to activate protein kinase C in vitro. 
Because of the complexity of the LPS molecule 
and its biological effects, other mechanisms may 
also be involved. Our observation that lipid X 
stimulates calmodulin-dependent phosphodiester- 
ase in vitro may account for some of its biological 
activities. Internalization of the relatively small, 
lipophilic lipid X molecule could potentially 
disrupt cyclic AMP-dependent processes by 
stimulation of intracellular cyclic AMP hydrolysis. 
Since increased cyclic AMP levels have an an- 
tagonistic effect on activation of inflammatory 
cells [7], lipid X could possibly promote or poten- 
tiate cellular activation by this mechanism. The 
findings of this study suggest that some of the im- 
munostimulatory effects of lipid X could be 
mediated by interaction with phosphodiesterase. 
Because lipid X may represent the minimal essen- 
tial structure for the biological activity of lipid A, 
this study also provides insight into the 
biochemistry of the cellular response to lipid A. 
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